Basis: FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.
The P/E ratio is N/A as of 2026-10-06T18:05:40.313Z.
Calculation as of: 2026-10-06T18:05:40.313Z.
Quote observation: 2026-10-06T18:00:20.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 2bec67efbd0228cb592a38c81264982f90af8fba553e645744a3942f8f5ba41c
PE RATIO
N/A
PE RATIO AVG TTM
34.37
PE RATIO AVG 3Y
N/A
PE RATIO AVG 5Y
N/A
PE RATIO AVG 10Y
N/A
PE RATIO AVG 15Y
N/A
PE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Market Cap
$13.07B
PE Ratio
32.91
TTM Avg
23.17
3Y Avg
20.17
5Y Avg
20.80
Market Cap
$12.84B
PE Ratio
282.87
TTM Avg
139.19
3Y Avg
74.59
5Y Avg
55.44
Market Cap
$14.48B
PE Ratio
21.12
TTM Avg
29.05
3Y Avg
39.77
5Y Avg
107.08
Market Cap
$14.54B
PE Ratio
15.82
TTM Avg
1263.90
3Y Avg
285.23
5Y Avg
278.76
| NAME | MARKET CAP | PE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Summit Therapeutics Inc. (SMMT) | $13.58B | N/A | 34.37 | N/A | N/A |
| BridgeBio Pharma, Inc. (BBIO)vs › | $13.11B | N/A | N/A | N/A | N/A |
| Halozyme Therapeutics, Inc. (HALO)vs › | $13.07B | 32.91 | 23.17 | 20.17 | 20.80 |
| Tempus AI, Inc. (TEM)vs › | $12.93B | N/A | N/A | N/A | N/A |
| Ascendis Pharma A/S (ASND)vs › | $14.30B | 17.49 | 18.80 | 18.80 | 18.80 |
| Corcept Therapeutics Incorporated (CORT)vs › | $12.84B | 282.87 | 139.19 | 74.59 | 55.44 |
| Neurocrine Biosciences, Inc. (NBIX)vs › | $14.48B | 21.12 | 29.05 | 39.77 | 107.08 |
| Jazz Pharmaceuticals plc (JAZZ)vs › | $14.54B | 15.82 | 1263.90 | 285.23 | 278.76 |
| Exelixis, Inc. (EXEL)vs › | $14.56B | 18.16 | 17.38 | 27.68 | 29.19 |
| Baxter International Inc. (BAX)vs › | $12.53B | N/A | 44.52 | 34.38 | 37.41 |
Trailing P/E
N/A
Forward P/E
N/A
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | PE RATIO |
|---|---|
| 2019-07-31 | 11.30 |
| 2019-07-30 | 11.21 |
| 2019-07-29 | 11.98 |
| 2019-07-26 | 12.33 |
| 2019-07-25 | 11.98 |
| 2019-07-24 | 11.73 |
| 2019-07-23 | 11.47 |
| 2019-07-22 | 10.79 |
| 2019-07-19 | 11.21 |
| 2019-07-18 | 11.21 |
| 2019-07-17 | 11.13 |
| 2019-07-16 | 11.56 |
| 2019-07-15 | 11.56 |
| 2019-07-12 | 11.47 |
| 2019-07-11 | 11.56 |
| 2019-07-10 | 11.56 |
| 2019-07-09 | 12.41 |
| 2019-07-08 | 11.13 |
| 2019-07-05 | 11.04 |
| 2019-07-03 | 10.70 |
| 2019-07-02 | 12.16 |
| 2019-07-01 | 11.21 |
| 2019-06-28 | 10.79 |
| 2019-06-27 | 11.21 |
| 2019-06-26 | 11.81 |
| 2019-06-25 | 12.41 |
| 2019-06-24 | 12.67 |
| 2019-06-21 | 12.67 |
| 2019-06-20 | 12.50 |
| 2019-06-19 | 12.33 |
| 2019-06-18 | 12.24 |
| 2019-06-17 | 12.07 |
| 2019-06-14 | 10.61 |
| 2019-06-13 | 10.79 |
| 2019-06-12 | 12.16 |
| 2019-06-11 | 12.33 |
| 2019-06-10 | 13.01 |
| 2019-06-07 | 13.10 |
| 2019-06-06 | 12.84 |
| 2019-06-05 | 13.01 |
| 2019-06-04 | 13.01 |
| 2019-06-03 | 13.10 |
| 2019-05-31 | 13.01 |
| 2019-05-30 | 12.84 |
| 2019-05-29 | 13.01 |
| 2019-05-28 | 13.27 |
| 2019-05-24 | 13.61 |
| 2019-05-23 | 13.87 |
| 2019-05-22 | 14.04 |
| 2019-05-21 | 14.55 |
| 2019-05-20 | 14.64 |
| 2019-05-17 | 13.78 |
| 2019-05-16 | 14.81 |
| 2019-05-15 | 13.70 |
| 2019-05-14 | 14.38 |
| 2019-05-13 | 14.81 |
| 2019-05-10 | 15.15 |
| 2019-05-09 | 15.15 |
| 2019-05-08 | 15.15 |
| 2019-05-07 | 15.49 |
| 2019-05-06 | 15.07 |
| 2019-05-03 | 15.15 |
| 2019-05-02 | 14.89 |
| 2019-05-01 | 13.78 |
| 2019-04-30 | 71.90 |
| 2019-04-29 | 76.37 |
| 2019-04-26 | 77.18 |
| 2019-04-25 | 77.58 |
| 2019-04-24 | 75.55 |
| 2019-04-23 | 80.83 |
| 2019-04-22 | 75.15 |
| 2019-04-18 | 77.58 |
| 2019-04-17 | 78.80 |
| 2019-04-16 | 82.05 |
| 2019-04-15 | 82.46 |
| 2019-04-12 | 76.77 |
| 2019-04-11 | 77.18 |
| 2019-04-10 | 79.21 |
| 2019-04-09 | 78.40 |
| 2019-04-08 | 80.83 |
| 2019-04-05 | 81.24 |
| 2019-04-04 | 74.33 |
| 2019-04-03 | 76.77 |
| 2019-04-02 | 73.12 |
| 2019-04-01 | 76.37 |
| 2018-10-31 | 33.33 |
| 2018-10-30 | 34.90 |
| 2018-10-29 | 33.72 |
| 2018-10-26 | 36.46 |
| 2018-10-25 | 35.88 |
| 2018-10-24 | 36.66 |
| 2018-10-23 | 37.44 |
| 2018-10-22 | 39.40 |
| 2018-10-19 | 36.86 |
| 2018-10-18 | 36.27 |
| 2018-10-17 | 38.23 |
| 2018-10-16 | 36.46 |
| 2018-10-15 | 36.46 |
| 2018-10-12 | 36.46 |
| 2018-10-11 | 36.27 |
| 2018-10-10 | 38.82 |
| 2018-10-09 | 39.99 |
| 2018-10-08 | 39.99 |
| 2018-10-05 | 40.58 |
| 2018-10-04 | 42.74 |
| 2018-10-03 | 42.15 |
| 2018-10-02 | 42.15 |
| 2018-10-01 | 41.56 |
| 2018-09-28 | 43.52 |
| 2018-09-27 | 43.72 |
| 2018-09-26 | 43.72 |
| 2018-09-25 | 43.91 |
| 2018-09-24 | 43.33 |
| 2018-09-21 | 44.70 |
| 2018-09-20 | 45.48 |
| 2018-09-19 | 45.87 |
| 2018-09-18 | 45.48 |
| 2018-09-17 | 45.29 |
| 2018-09-14 | 44.70 |
| 2018-09-13 | 41.56 |
| 2018-09-12 | 43.13 |
| 2018-09-11 | 42.93 |
| 2018-09-10 | 42.15 |
| 2018-09-07 | 43.13 |
| 2018-09-06 | 42.35 |
| 2018-09-05 | 44.31 |
| 2018-09-04 | 45.68 |
| 2018-08-31 | 46.07 |
| 2018-08-30 | 48.03 |
| 2018-08-29 | 43.52 |
| 2018-08-28 | 41.36 |
| 2018-08-27 | 40.19 |
| 2018-08-24 | 40.19 |
| 2018-08-23 | 41.76 |
| 2018-08-22 | 39.60 |
| 2018-08-21 | 40.19 |
| 2018-08-20 | 39.99 |
| 2018-08-17 | 40.78 |
| 2018-08-16 | 42.35 |
| 2018-08-15 | 40.19 |
| 2018-08-14 | 44.11 |
| 2018-08-13 | 46.07 |
| 2018-08-10 | 45.68 |
| 2018-08-09 | 46.07 |
| 2018-08-08 | 46.27 |
| 2018-08-07 | 46.07 |
| 2018-08-06 | 48.42 |
| 2018-08-03 | 47.83 |
| 2018-08-02 | 46.66 |
| 2018-08-01 | 45.68 |
